ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for SPYRE THERAPEUTICS, INC. · Biotechnology company focused on treatments for gastrointestinal and rheumatic diseases.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $10,000.00 income · posted Jul 17, 2026

Lobbying activity 1

Health Issues

Issues related to monoclonal antibody products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.